Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.

Lucas C Duits, Myrtle J van der Wel,Cary C Cotton,K Nadine Phoa,Fiebo J W Ten Kate,Cees A Seldenrijk,G Johan A Offerhaus,Mike Visser,Sybren L Meijer,Rosalie C Mallant-Hent,Kausilia K Krishnadath,Roos E Pouw,Jan G P Tijssen,Nicholas J Shaheen,Jacques J G H M Bergman

Gastroenterology（2017）

引用 89|浏览14

暂无评分

摘要

The number of pathologists confirming LGD and persistence of LGD over time increase risk for development of HGD or EAC in patients with Barrett's esophagus and LGD. These simple, readily available variables can help stratify risk and select patients for prophylactic ablation therapy.

查看译文

关键词

SURF Trial,Esophageal Cancer,Histopathology,Prognostic Factor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要